This panel analyzes genes associated with Primary Immunodeficiencies (PIs)—a group of inherited conditions where components of the immune system are absent or dysfunctional. Individuals with PIs often experience recurrent, severe, or unusual infections, and may also face risks of autoimmunity or malignancy. Early genetic diagnosis supports timely treatment, including immunoglobulin therapy or stem cell transplantation, and informs family risk and carrier status.
Over 450 distinct Primary Immunodeficiency (PI) disorders have been identified, many of which extend beyond the classic presentation of frequent infections. Some PIs manifest predominantly through autoimmune symptoms, chronic inflammation, or even malignancies. These overlapping features often delay diagnosis. Genetic testing is now a key tool in uncovering rare immune system defects, enabling earlier intervention and tailored therapies that can transform long-term outcomes and quality of life.
Elite Clinical Laboratory offers detailed interpretation of PI-related findings, supporting accurate and timely diagnoses. We coordinate with immunologists and certified genetic counselors to guide treatment planning—whether it involves immunoglobulin therapy, bone marrow transplantation, or long-term monitoring. Our approach ensures providers have the context needed to deliver comprehensive care and counsel families on risk, inheritance, and next steps for managing these often-complex conditions.